Article
TNFSF13B rs9514828 C>T Polymorphism is Associated with Incidence of Atherosclerosis and…
Biologics: Targets and Therapy · 2024 · Fajar DR, Rostinawati T, Hamijoyo L, Sahiratmadja E, Amalia R, Barliana MI
Key facts
| Title | TNFSF13B rs9514828 C>T Polymorphism is Associated with Incidence of Atherosclerosis and Therapeutic Outcomes in Patients with Systemic Lupus Erythematosus |
|---|---|
| First author | Fajar DR, Rostinawati T, Hamijoyo L, Sahiratmadja E, Amalia R, Barliana MI |
| Journal | Biologics: Targets and Therapy |
| Published | May 3, 2024 |
| DOI | 10.2147/BTT.S452792 |
| Devices mentioned | 215650, 218272, K973350, K990827, K993107 |
| Product codes mentioned | JLX, KQP, LPS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1